Localized scleroderma, as the term denotes, is localized to the skin on the hands and face. It is characterized by slow progression and rarely transforms to the systemic type. Localized scleroderma is ...

Localized scleroderma is a rare connective tissue disorder characterized by hardening and thickening of the skin due to increased collagen density. A quarter of patients affected also experience ...

Scleroderma (meaning “hard skin” in Greek) is synonymous with morphea, although the latter term is usually reserved for a benign form of localized disease. All forms of scleroderma are ultimately ...

Padua, Italy - Although juvenile localized scleroderma is typically thought of as a skin disease, Dr Francesco Zulian reports in the September 2005 issue of Arthritis & Rheumatism that 22.4% of ...

Given the potential significant morbidity of linear scleroderma, it is important to identify treatment approaches that can improve outcomes. This study provides another dataset that supports the use ...

The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...

Clinical enrollment for an open-label, single-arm Phase 1/2 trial of FCX-013 was initiated in August 2018. Fibrocell Science announced that the Food and Drug Administration (FDA) has granted Fast ...

Scleroderma diagnosis is rather difficult as the symptoms of the disease overlap with those of other conditions. Therefore, it becomes necessary to rule out other auto immune diseases before focusing ...

EXTON, Pa., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue ...

A reader writes in to note that June is scleroderma month and points out that more Canadians have this disease than those with cystic fibrosis, multiple sclerosis or muscular dystrophy combined. She ...

EXTON, Pa., Oct. 15, 2020 /PRNewswire/ -- Castle Creek Biosciences, Inc, a privately-held, clinical-stage cell and gene therapy company leveraging its proprietary fibroblast technology platform to ...